Clinical trials of Remedesivir drug will be done in India soon after the US. These tests will be initiated in collaboration with the World Health Organization (WHO). According to Health Ministry sources, teams of CSIR and ICMR are working on it. WHO has received one thousand Remedesvir vials from India, which will be used in some states.
However, this drug will only be given to serious patients of Corona. After trials in the US, scientists have claimed that the use of this drug improves rapidly in patients with severe corona. However, this drug was intended for infection with Ebola virus.
Remedicivir, an antiviral drug used in the treatment of corona in the US, will be available from next week. The US body Food and Drug Administration approved the use of this drug in emergency.
Management of the drug maker Gilead Sciences says that the manufacturing of the drug is going on fast in the company so that it can be provided to more and more people. The company’s CEO Dan O said that the company is also working fast on making Corona’s vaccine.